How to best appreciate the possible clinical role of cardiac 123I-mIBG scintigraphy in heart failure patients: Trying not to get lost while going in the right direction!
- PMID: 31538324
- DOI: 10.1007/s12350-019-01895-6
How to best appreciate the possible clinical role of cardiac 123I-mIBG scintigraphy in heart failure patients: Trying not to get lost while going in the right direction!
References
-
- Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21. - DOI
-
- Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, Katsikis A, et al. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. Eur Heart J Cardiovasc Imaging 2014;15:996-1003. - DOI
-
- Maisel A. Biomonitoring and biomarker-guided therapy: The next step in heart failure and biomarker research. J Am Coll Cardiol 2011;58:1890-2. - DOI
-
- Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5. - DOI
-
- Kirkfeldt RE, Johansen JB, Nohr EA, Jorgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: An analysis of a complete, nationwide cohort in Denmark. Eur Heart J 2014;35:1186-94. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
